Genotyping and artificial intelligence are together starting to predict the progression of glaucoma in individual patients, sparing them from suboptimal treatments and side effects. Recent research efforts are exploring modifiable risk factors such as caffeine consumption. During this episode, Dr Anthony Khawaja chats with Scott Buckler about the need for precision management in glaucoma.
